抗体
试剂盒
多肽
探针
蛋白
组织芯片
产品中心
Product Center
Research Grade Navicixizumab
All
TD-HV571036_1.jpg
TD-HV571036_2.jpg
- Catalog： TD-HV571036
- Clonality： mAb
- Application： Research Grade Biosimilar
- Synonyms： Bispecific,OMP-305B83,CAS:1638338-43-8
-
规格：
1mg
-
价格：
¥询价
定制服务咨询
Research Grade Navicixizumab
| Catalog No. | TD-HV571036 |
|---|---|
| Species reactivity | Human |
| Applications | Research Grade Biosimilar |
| Host species | Humanized |
| Isotype | IgG2-kappa |
| Expression system | Mammalian Cells |
| Clonality | Monoclonal |
| Target | Delta-like protein 4, Drosophila Delta homolog 4, Delta4, DLL4, Vascular endothelial growth factor A, VPF, VEGFA, VEGF, Vascular permeability factor, VEGF-A |
| Endotoxin level | Please contact the lab for this information. |
| Purity | >95% purity as determined by SDS-PAGE. |
| Purification | Protein A/G, purified from cell culture supernatant. |
| Accession | Q9NR61 & P15692 |
| Form | Liquid |
| Storage buffer | 0.01M PBS,pH7.4. |
| Stability and Storage | Use a manual defrost freezer and avoid repeated freeze-thaw cycles. Store at 4°C for short-term storage (1-2 weeks). Store at -20°C for up to 12 months. For long-term storage, store at -80°C. |
| Alternate Names | Bispecific,OMP-305B83,CAS:1638338-43-8 |
| Background | Navicixizumab (OMP-305B83) is a bispecific anti-VEGF and anti-DLL4 inhibitory antibody. Navicixizumab can combine with Paclitaxel (HY-B0015) for cancer research. Navicixizumab can be used in the research of ovarian, primary peritoneal, or fallopian tube cancer. |
| Note | For research use only. Not for use in clinical or therapeutic applications. |
|
SEC-HPLC |
SEC-HPLC detection for Research Grade Navicixizumab. |
|
Bioactivity |
Detects DLL4 in indirect ELISAs. |